HRTX
Heron Therapeutics Inc
Price:
1.87
USD
Volume:
631,584
United States | Biotechnology
HRTX Gross Margin
As of 2025-05-23, the Gross Margin of Heron Therapeutics Inc (HRTX) is 73.2%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
HRTX Gross Margin - Historical Value
| Date | Value |
|---|---|
| 2024-12-31 | 73.2% |
| 2023-12-31 | 48.8% |
| 2022-12-31 | 49% |
| 2021-12-31 | 46.7% |
| 2020-12-31 | 59.1% |
| 2019-12-31 | 57.8% |
| 2018-12-31 | 64.5% |
| 2017-12-31 | 85.1% |
| 2016-12-31 | 92.3% |
| 2015-12-31 | - |
HRTX Gross Margin - Peers Comparison